Latest / Community Health Media
This Moment in Medicine: Rethinking Adjuvant Therapy in ER+ Breast Cancer with Dr. Akshjot Puri
How is adjuvant treatment for ER-positive, HER2-negative breast cancer changing?
At This Moment in Medicine, Dr. Akshjot Puri examines key data from OPTIMA, lidERA, NATALEE, and monarchE—and what these trials could mean for chemotherapy de-escalation, endocrine therapy, ovarian suppression, and CDK4/6 inhibitor use.
From using Prosigna to identify patients who may be able to avoid chemotherapy to the emerging role of oral SERDs, the presentation highlights how treatment is becoming increasingly individualized based on risk, biology, and patient needs.
Topics discussed:
OPTIMA and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.